Tacrolimus withdrawal and conversion to sirolimus at three months post-pediatric renal transplantation

Pediatric Transplantation

Volumn 12, Issue 7, 2008, Pages 773-777

  Hymes, Leonard C ^a,b   Warshaw, Barry L ^b   Amaral, Sandra G ^b   Greenbaum, Larry A ^b  

^a Division of Nephrology   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Renal transplant; Sirolimus; Tacrolimus

Indexed keywords

ATORVASTATIN; BASILIXIMAB; CORTICOSTEROID; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; APHTHOUS ULCER; ARTICLE; BIOPSY; DIABETES MELLITUS; DIARRHEA; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRAFT SURVIVAL; HUMAN; HYPERCHOLESTEROLEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; PNEUMONIA; PROTEINURIA; SCHOOL CHILD; THROMBOCYTOPENIA; VIREMIA; WOUND HEALING; WOUND HEALING IMPAIRMENT;

BIOPSY; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; HUMANS; HYPERCHOLESTEROLEMIA; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; RETROSPECTIVE STUDIES; SIROLIMUS; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 53849114660     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.00906.x     Document Type: Article

References (26)

1. Tocci MJ, Sigal NH. Recent advances in the mechanism of action of cyclosporine and FK506. Curr Opin Nephrol Hypertens 1992 : 1 : 236 242.
2. Van Buren DH, Burke JF, Lewis RM. Renal function in patients receiving long-term cyclosporine therapy. J Am Soc Nephrol 1994 : 8 (Suppl. S17 S22.
3. Helderman JH, Van Buren DH, Amend WJ, Pirsch JD. Chronic immunosuppression of the renal transplant patient. J Am Soc Nephrol 1994 : 8 (Suppl. S2 S9.
4. Matas AJ, Burke JF, DeVault GA, Monaco A, Pirsch JD. Chronic rejection. J Am Soc Nephrol 1994 : 8 (Suppl. S23 S29.
5. McNally PG, Feehally J. Pathophysiology of cyclosporin A nephrotoxicity: Experimental and clinical observations. Nephrol Dial Transplant 1992 : 7 : 791 804.
6. Groth CG, Backman L, Morles JM, et al. Sirolimus (rapamycin)-based therapy in human renal transplantation. Similar efficacy and different toxicity with cyclosporine. Transplantation 1999 : 67 : 1036 1042.
7. Kahan BD, Julian BA, Pecscovitz MD, Vanrenterghem Y, Neeyaln J. Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine dose in Caucasian recipients of mismatched primary renal allografts: A phase II trial. Transplantation 1999 : 68 : 152 1532.
8. Sehgal S. Rapamune (RAPA, rapamycin, sirolimus): Mechanism of action immunosuppression effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 1998 : 31 : 335 340.
9. Hymes LC, Warshaw BL. Sirolimus in pediatric patients: Results in the first 6 months post-renal transplant. Pediatr Transplant 2005 : 9 : 520 522.
10. Dean PG, Lund WJ, Larson TS, et al. Wound healing complications in transplantation: A prospective, randomized comparison of sirolimus and tacrolimus. Transplantation 2004 : 77 : 1555 1561.
11. Hymes LC, Greenbaum L, Amaral SG, Warshaw BL. Surveillance renal transplant biopsies and sublcinical rejection at three months post-transplant in pediatric recipients. Pediatr Transplant 2007 : 11 : 536 539.
12. Hymes LC, Warshaw BL. Polyomavirus (BK) in pediatric renal transplants: Evaluation of viremic patients with and without BK associated nephritis. Pediatr Transplant 2006 : 10 : 920 922.
13. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987 : 34 : 571 590.
14. Morelon E, Stern M, Israel-Biet D, et al. Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients. Transplantation 2001 : 72 : 787 790.
15. Falger JC, Mueller T, Arbeiter K, et al. Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy. Pediatr Transplant 2006 : 10 : 565 569.
16. Hocker B, Feneberg R, Kopf S, et al. SRL-based immunosuppression vs. CNI minimization in pediatric renal transplant recipients with chronic CNI nephrotoxicity. Pediatr Transplant 2006 : 10 : 593 601.
17. Butani L. Investigation of pediatric renal transplant recipients with heavy proteinuria after sirolimus rescue. Transplantation 2004 : 78 : 1362 1366.
18. Peddi VR, Jensik S, Pescovitz M, et al. An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency. Clin Transplant 2005 : 19 : 130 136.
19. Bumbea V, Kamar N, Ribes D, et al. Long-term results in renal transplant patients with allograft dysfunciton after switching from calcineurin inhibitors to sirolimus. Nephrol Dial Transplant 2005 : 20 : 2517 2523.
20. Ruiz JC, Campistol JM, Sanchez-Fructosa A, et al. Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction. Nephrol Dial Transplant 2006 : 21 : 3252 3257.
21. Sennesael JJ, Bosmans JL, Bogers JP, Verbeelen D, Verpooten GA. Conversion from cyclosporine to sirolimus in stable renal transplant recipients. Transplantation 2005 : 80 : 1578 1585.
22. Egidi MF, Cowan PA, Naseer A, Gaber AO. Conversion to sirolimus in solid organ transplantation: A single-center experience. Transplant Proc 2003 : 3 (Suppl. 131S 137S.
23. Sundberg AK, Rohr MS, Hartmann EL, Adams PL, Stratta RJ. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients. Clin Transplant 2004 : 18 (Suppl. 12 61 66.
24. Harmon W, Meyers K, Ingelfinger J, et al. Safety and efficacy of a calcineurin inhibitor avoidance regimen in pediatric renal transplantation. J Am Soc Nephrol 2006 : 17 : 1735 1745.
25. Larson TS, Dean PG, Stegall MD, et al. Complete avoidance of calcineurin inhibitors in renal transplantation: A randomized trial comparing sirolimus and tacrolimus. Am J Transplant 2006 : 6 : 514 522.
26. Daloze DL, Ekberg H, Vincenti F, Tedesco-Silva H, Pearson T. Low dose sirolimus in the first 8 weeks following renal transplantation accompanied by daclizumab induction, MMF and steroids: The experience of the SYMPHONY study. J Am Soc Nephrol 2006 : 17 (Suppl. 563A.